Statins and ARBs on Rheumatoid Activity
Recruiting · NCT03770702 · Interventional (participants receive a specific treatment) · Lead sponsor: Sherief Abd-Elsalam
View the official record on ClinicalTrials.gov →Interventions studied
Angiotensin receptor blockersStatins
What this trial is about
Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients
Who can take part
Age range
18 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Rheumatoid arthritis.
Exclusion criteria
- Pregnant or lactating
- Hepatic or renal impairment.
Where it is running
1 location listed.
- Sherief Abd-Elsalam - Tanta, Egypt